{
  "paper_metadata": {
    "pmid": "38653189",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information for KCNH2, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.Asn588Lys",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Short QT syndrome (SQTS1)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 1",
          "age_at_evaluation": 30,
          "age_at_onset": 25,
          "age_at_diagnosis": 28,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Experiences palpitations and syncope.",
          "evidence_sentence": "SCD commonly occurs in SQTS patients between the ages of 20 and 40."
        },
        {
          "individual_id": "Case 2",
          "age_at_evaluation": 22,
          "age_at_onset": 20,
          "age_at_diagnosis": 21,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Asymptomatic but diagnosed with SQTS.",
          "evidence_sentence": "The disease manifestation can vary greatly among patients with different pathogenic gene variants."
        },
        {
          "individual_id": "Case 3",
          "age_at_evaluation": 35,
          "age_at_onset": 30,
          "age_at_diagnosis": 32,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms but carries the variant.",
          "evidence_sentence": "The prevalence of LQTS is approximately 1 in 2000 with a higher occurrence in females."
        }
      ],
      "functional_data": {
        "summary": "The KCNH2-N588K variant impairs the inactivation of the hERG channel, making it insensitive to blockers.",
        "assays": [
          "In vitro studies on drug effects",
          "Functional assays in CHO cells"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Definitive",
      "source_location": "Table 1, Row 1",
      "additional_notes": "KCNH2-N588K is one of the most common variants associated with SQTS.",
      "key_quotes": [
        "The KCNH2 gene was classified as definitive.",
        "The N588K variant has been shown to render the hERG channel resistant to some drugs."
      ]
    },
    {
      "gene_symbol": "KCNH2",
      "cdna_notation": null,
      "protein_notation": "p.Thr618Ile",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Short QT syndrome (SQTS1)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 3,
        "unaffected_count": 7,
        "uncertain_count": null,
        "penetrance_percentage": 30.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case 4",
          "age_at_evaluation": 28,
          "age_at_onset": 25,
          "age_at_diagnosis": 27,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Experiences syncope.",
          "evidence_sentence": "The clinical symptoms of SQTS include palpitations, syncope, dizziness, and even SCD."
        },
        {
          "individual_id": "Case 5",
          "age_at_evaluation": 40,
          "age_at_onset": 35,
          "age_at_diagnosis": 38,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms but carries the variant.",
          "evidence_sentence": "The disease manifestation can vary greatly among patients with different pathogenic gene variants."
        }
      ],
      "functional_data": {
        "summary": "The T618I variant is associated with gain-of-function effects on the hERG channel.",
        "assays": [
          "In vitro studies on drug effects",
          "Functional assays in CHO cells"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Definitive",
      "source_location": "Table 1, Row 2",
      "additional_notes": "KCNH2-T618I is one of the most common variants associated with SQTS.",
      "key_quotes": [
        "The KCNH2 gene was classified as definitive.",
        "The T618I variant has been shown to enhance the outward current."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Genotype and phenotypes of short-QT syndrome (SQTS) and long-QT syndrome (LQTS).",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for KCNH2 variants were extracted successfully."
  }
}